KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
$24.50
0.00%
(0.00) 1D
Oct 1, 10:21:43 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KSPHF...
Mkt. cap
172.67B
Avg. vol.
20.00
Volume
0.00
52-wk high
$31.90
52-wk low
$24.50
Beta
13.94
Shares outstanding
46.54M
No. of employees
2K
Mkt. cap
172.67B
Avg. vol.
20.00
Volume
0.00
52-wk high
$31.90
52-wk low
$24.50
Beta
13.94
Shares outstanding
46.54M
No. of employees
2K
News stories
From web sources and news partners
FXStreet
·
37 minutes ago
S&P 500: Earnings strength offsets yield headwinds – HSBC
www.marketscreener.com
·
1 hour ago
Hong Kong Exchanges and Clearing : HKEX Launches S&P 500 & HKEX Tech 100 Index in Partnership with S&P Dow Jones Indices
Reuters
·
41 minutes ago
Wall Street's big but narrow rally: 4 in 10 S&P stocks are down this year
FXLeaders
·
11 hours ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1.79K
FoundedAug 9, 1946
HeadquartersMatsumoto, Nagano, Japan
SectorPharmaceutical industry
Websitekissei.co.jp